Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omeprazole and gliclazide interaction in CYP2C19 normal/ultrarapid metabolisers
NCT04198948Phase 1Completed
- Sponsor
- University of Sarajevo
- Start
- Mar 2019
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of omeprazole in Gastrointestinal disorder (2 arms), sponsored by University of Sarajevo. Primary endpoint: Area Under the Curve at 24 hours. Started Mar 2019; status: completed.
02
Drugs
omeprazole
03
Conditions
Gastrointestinal disorder
Beyond the preview
Go deeper on NCT04198948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04198948.